Table 2.

Univariate logistic regression analysis of MVI presence based on preoperative data in the training cohort.

Variable	OR	95% CI	Z-score	p value
Age (year)	0.99	0.97–1.02	0.40	0.688
Gender	0.49	0.17–1.22	1.46	0.144
BMI (kg/m2)	0.97	0.90–1.04	0.86	0.390
Liver disease etiology	1.09	0.19–8.42	0.10	0.922
Platelet (*109/L)	2.39	1.42–4.10	3.23	0.001
WBC (*109/L)	1.10	0.99–1.22	1.79	0.074
Neutrophil (*109/L)	1.10	0.98–1.24	1.56	0.118
Monocyte (*109/L)	1.79	0.81–4.41	1.38	0.166
Lymphocyte (*109/L)	1.19	0.78–1.84	0.80	0.424
PLR	2.20	1.25–3.99	2.67	0.008
NLR	1.01	0.97–1.06	0.63	0.529
LMR	0.96	0.84–1.07	0.68	0.499
Albumin (g/dL)	1.10	0.36–3.73	0.16	0.873
Bilirubin (μmol/L)	1.99	1.07–3.72	2.18	0.030
ABR	0.87	0.73–1.02	1.66	0.096
INR	1.19	0.85–1.66	1.01	0.312
Creatinine (μmol/L)	1.00	0.10–1.01	0.97	0.333
Child-Pugh score	1.08	0.97–1.23	1.36	0.174
MELD Score	1.02	0.99–1.05	1.44	0.149
HBsAb	2.11	0.98–4.64	1.89	0.059
HBsAg	1.21	0.56–2.74	0.47	0.642
HBeAb	1.18	0.71–1.98	0.65	0.519
HBeAg	0.87	0.47–1.58	0.47	0.639
TACE	1.26	0.753–2.100	0.87	0.383
Diabetes	1.14	0.52–2.46	0.33	0.743
Intractable ascites	1.07	0.54–2.07	0.19	0.850
AFP (ng/mL)	8.87	4.48–18.76	6.01	<0.001
Tumor size (cm)	7.02	3.96–12.73	6.56	<0.001
Peritumoral star node	6.56	3.76–11.72	6.50	<0.001
Tumor margin	4.34	2.20–9.26	4.03	<0.001
Number of tumors	3.04	1.77–5.30	3.99	<0.001
Pseudo-capsule	0.70	0.420–1.18	1.33	0.185

Abbreviations: MVI, microvascular invasion; OR, odds ratio; CI, confidence interval; BMI, body mass index; WBC, white blood count; PLR, platelet-to-lymphocyte ratio; NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; ABR, albumin to bilirubin ratio; INR, international normalized ratio; MELD Score, Model for End-stage Liver Disease score; TACE, transcatheter arterial chemoembolization; AFP, α-fetoprotein.